Asia Pacific Immunoassays in R&D Market By Product & Services Forecast (2015-2023)

Year AUSTRALIA CHINA INDIA JAPAN SOUTH KOREA REST OF ASIA PACIFIC
2015 $ 118.1 $ 185.0 $ 159.7 $ 229.7 $ 84.2 $ 58.7
2016 $ 129.4 $ 202.9 $ 171.4 $ 252.1 $ 92.1 $ 64.2
2017 $ 141.4 $ 221.9 $ 184.0 $ 276.0 $ 100.5 $ 70.0
2018 $ 153.8 $ 241.6 $ 197.5 $ 300.9 $ 109.2 $ 75.9
2019 $ 167.2 $ 262.7 $ 213.1 $ 327.8 $ 118.4 $ 81.8
2020 $ 182.1 $ 286.4 $ 232.1 $ 358.0 $ 127.9 $ 88.2
2021 $ 199.2 $ 314.3 $ 256.5 $ 393.9 $ 138.5 $ 95.4
2022 $ 217.8 $ 347.0 $ 288.0 $ 435.9 $ 150.2 $ 103.3
2023 $ 236.5 $ 381.7 $ 323.3 $ 480.8 $ 162.2 $ 111.1
  • To Get Uninterrupted Charts Access Please Subscribe
  • Dedicated Client Service Manager
  • Dedicated Analyst Support
  • View access to 2 million data
Asia Pacific Immunoassays in R&D Market By Product & Services Forecast (2015-2023)

Synopsis
The above chart is Global Immunoassays in R&D market [2015-2023] Asia Pacific by Product & Services

Market Dynamics

Japan accounted for the largest market share in 2017 in the asia pacific immunoassays in r&d market, and is expected to reach usd 480.80 million in 2023 from usd 276.00 million in 2017. however, india is the fastest growing market, which is expected to grow at a cagr of 10.36% during the forecast period 2018 - 2023. kits and reagents segment accounted for the largest market share in 2017, this market is expected to reach usd 810.40 million in 2023 from usd 457.90 million in 2017. this market is projected to grow at a cagr of 10.33% during the forecast period from 2018 - 2023. however, kits and reagents segment is the fastest growing market, which is expected to grow at a cagr of 10.33% during the forecast period 2018 - 2023. endocrinology segment accounted for the largest market share in 2017, this market is expected to reach usd 564.00 million in 2023 from usd 302.30 million in 2017. this market is projected to grow at a cagr of 11.51% during the forecast period from 2018 - 2023. however, endocrinology segment is the fastest growing market, which is expected to grow at a cagr of 11.51% during the forecast period 2018 - 2023. pharmaceutical and biotechnology companies segment accounted for the largest market share in 2017, this market is expected to reach usd 811.50 million in 2023 from usd 479.70 million in 2017. this market is projected to grow at a cagr of 9.24% during the forecast period from 2018 - 2023. however, academic institutions and laboratories segment is the fastest growing market, which is expected to grow at a cagr of 10.48% during the forecast period 2018 - 2023. elisa segment accounted for the largest market share in 2017, this market is expected to reach usd 521.10 million in 2023 from usd 313.50 million in 2017. this market is projected to grow at a cagr of 8.84% during the forecast period from 2018 - 2023. however, enzyme linked immunospot assay elispot segment is the fastest growing market, which is expected to grow at a cagr of 11.79% during the forecast period 2018 - 2023.

Further Content:You might find this interesting as well

Industries List

SINGLE SEAT SOLUTIONS FOR INDIVIDUALS AND SMALL BUSINESSES
Efficient research: Relevant data available at a click

Starter Account

$49 USD/month

* Billed Annually

  • Download XLS, PNG & PPT
  • View Access to 1 Million Data
  • View Access to Entire Platform

Single User Account

$599 USD/month

* Billed Annually

  • Dedicated Client Service Manager
  • Download XLS, PNG & PPT
  • View access to 2 million data
  • View Access to Entire Platform

Business Account

$899 USD/month

* Billed Annually

  • Dedicated Client Service Manager
  • Dedicated Analyst Support
  • Suggestive request box to accommodate new markets during subscription period
  • Access to the entire data & statistics with download rights for up to 10000 Premium statistics per 12 months without publication rights
  • View Access to Entire Platform
CONTACT

Closebutton

Stay Ahead with Exclusive Data!

Subscribe Now to Access Our Market Research Platform,and Charts
for B2B and B2C Industries. Empower Your Business with Insights